Sunshine Biopharma (SBFM) Stock Price, Quote & News

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pa...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 954 330 0684

Website: sunshinebiopharma.com

Address:

333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States

contra7 Mar. 21 at 6:37 PM

$SBFM The most undervalued oncology focused biotech in the entire market.

0 · Reply

Suomalainen Mar. 21 at 1:28 PM

$SBFM https://www.facebook.com/photo/?fbid=122285085794029109&set=gm.4313979155480907&idorvanity=3471414236404074&__cft__[0]=AZaQqBOe8QAzZaQZoWdwmTKGw3dMJ0-xcvokgN09zU3BRDVdEtZMkITgyIdYj-CfaOJhpZIteQxaI9j-pBOAb7_93cPr33vB6VsZh7XrCU7pUyb8sUFcEoOqdNSdEFCQsdMnV7dEkPvxrvL1KI1_4EP_VapINT7xGzWDoOyKREbGN9A2089mDit5Er4EWtU24QvGo_QPl7_J-g5LoU7_E8W0&__tn__=EH-R

1 · Reply

Ejannsen Mar. 21 at 5:23 AM

$SBFM Stick a fork in it…

0 · Reply

Kalini67 Mar. 21 at 12:14 AM

$SBFM For a dead stock it’s holding pretty well!

0 · Reply

MS121 Mar. 20 at 11:15 PM

$SBFM This is clearly done. Reverse split, dilution repeat.

2 · Reply

RonRon1234 Mar. 20 at 11:10 PM

$SBFM new 52 week low! Woot woot! Fml

0 · Reply

Masterrunner Mar. 20 at 6:28 PM

$SBFM Slilaty paid $22M for Nora, and somehow the bulls think he’s flipping it for $600M in under four years. Not a turnaround story; just a masterclass in delusion. 😂

1 · Reply

Kalini67 Mar. 20 at 4:32 PM

$SBFM We will hold through tough time no matter what, not sweating this out on a recession, the final lap is on sight so the question will be be ”are you going to be there”!

0 · Reply

Kalini67 Mar. 20 at 4:03 PM

$SBFM Remarkable sbfm stock holdind despite overral market sentiment, someone is catching the last shares, someone is accumulating and is not retail investors!

0 · Reply

samheams Mar. 20 at 2:34 PM

$SBFM a buyout here seems likely in my opinion with the reduced market cap. Someone is bound to come in and take over for around 7.5m and that would be a great deal for all involved. I’m in and waiting for 1.50!

2 · Reply

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

Oct 28, 2025, 7:45 AM EDT - 5 months ago

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

Oct 20, 2025, 7:45 AM EDT - 5 months ago

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Oct 16, 2025, 7:45 AM EDT - 5 months ago

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 14, 2025, 10:45 AM EDT - 5 months ago

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025, 8:50 AM EDT - 5 months ago

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

Oct 14, 2025, 7:00 AM EDT - 5 months ago

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Oct 9, 2025, 8:00 AM EDT - 5 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

Jul 2, 2025, 8:00 AM EDT - 9 months ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Jun 11, 2025, 8:30 AM EDT - 10 months ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

May 15, 2025, 4:15 PM EDT - 11 months ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

May 6, 2025, 8:30 AM EDT - 11 months ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

Apr 21, 2025, 8:30 AM EDT - 11 months ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 3, 2025, 10:50 AM EDT - 1 year ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 2, 2025, 1:20 PM EDT - 1 year ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Apr 2, 2025, 11:35 AM EDT - 1 year ago

Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Apr 1, 2025, 5:09 PM EDT - 1 year ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Jan 21, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 15, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Dec 9, 2024, 7:30 AM EST - 1 year ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Dec 4, 2024, 4:05 PM EST - 1 year ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 2, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Nov 6, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Aug 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Aug 19, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Aug 6, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Reverse Stock Split

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Feb 15, 2024, 9:15 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Feb 13, 2024, 9:00 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Dec 4, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Moves Principal Office to New York City

Nov 13, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Sep 21, 2023, 9:05 PM EDT - 2 years ago

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Aug 11, 2023, 8:30 AM EDT - 2 years ago

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

May 16, 2023, 2:15 PM EDT - 3 years ago

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

May 16, 2023, 9:58 AM EDT - 3 years ago

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

May 12, 2023, 8:00 AM EDT - 3 years ago

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

May 11, 2023, 9:00 AM EDT - 3 years ago

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

Apr 5, 2023, 8:00 AM EDT - 3 years ago

Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update

Feb 28, 2023, 7:30 AM EST - 3 years ago

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment

Feb 10, 2023, 7:35 AM EST - 3 years ago

Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound

Jan 19, 2023, 7:30 AM EST - 3 years ago

Sunshine Biopharma Announces Share Repurchase Program

Dec 20, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma's Annual Letter to Shareholders

Dec 5, 2022, 5:46 PM EST - 3 years ago

4 Stocks Meeting GuruFocus' Value Screens in December

RM CACC WFG

Nov 16, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project

contra7 Mar. 21 at 6:37 PM

$SBFM The most undervalued oncology focused biotech in the entire market.

0 · Reply

Suomalainen Mar. 21 at 1:28 PM

1 · Reply

Ejannsen Mar. 21 at 5:23 AM

$SBFM Stick a fork in it…

0 · Reply

Kalini67 Mar. 21 at 12:14 AM

$SBFM For a dead stock it’s holding pretty well!

0 · Reply

MS121 Mar. 20 at 11:15 PM

$SBFM This is clearly done. Reverse split, dilution repeat.

2 · Reply

RonRon1234 Mar. 20 at 11:10 PM

$SBFM new 52 week low! Woot woot! Fml

0 · Reply

Masterrunner Mar. 20 at 6:28 PM

$SBFM Slilaty paid $22M for Nora, and somehow the bulls think he’s flipping it for $600M in under four years. Not a turnaround story; just a masterclass in delusion. 😂

1 · Reply

Kalini67 Mar. 20 at 4:32 PM

$SBFM We will hold through tough time no matter what, not sweating this out on a recession, the final lap is on sight so the question will be be ”are you going to be there”!

0 · Reply

Kalini67 Mar. 20 at 4:03 PM

$SBFM Remarkable sbfm stock holdind despite overral market sentiment, someone is catching the last shares, someone is accumulating and is not retail investors!

0 · Reply

samheams Mar. 20 at 2:34 PM

2 · Reply

Masterrunner Mar. 19 at 10:50 PM

$SBFM Every time RS comes up with this crew, it’s 100%. No delays, no surprises; just exactly what they said. Anyone still bullish here is ignoring a very obvious pattern. NFA.

1 · Reply

Suomalainen Mar. 19 at 6:24 PM

$SBFM Is it going to dip under $1.00 ??

1 · Reply

Kalini67 Mar. 19 at 3:57 PM

$SBFM Am Loving it , I add up on the market sentiment, nothing to see here

0 · Reply

MS121 Mar. 19 at 3:34 PM

$SBFM what a disaster

0 · Reply

OfficialStocktwitsUser Mar. 19 at 1:28 PM

$SBFM RSI: 30.30, MACD: -0.0279 Vol: 0.04, MA20: 1.15, MA50: 1.20 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

MB66 Mar. 18 at 6:22 PM

$SBFM not sure what to make of this. The last report of this type by LSEG covering SBFM was just released on 3/10/26. This one here from today. Do they just release a weekly report once they are covering a stock? Or did they update and release a new report?

1 · Reply

The_Matrix_reloaded_2020 Mar. 18 at 6:16 PM

$SBFM Been in this a long time. 44% down with an SP average of $1.93 Possibly not the smartest move in this market, but I'm doubling down today to get me to around $1.50 Hmmm 🤔...

1 · Reply

Ejannsen Mar. 18 at 5:52 PM

$SBFM Extremely

0 · Reply

Ejannsen Mar. 18 at 5:51 PM

$SBFM Management has burned their shareholders a few to many times. No volume. A fitting demise for this POS.!

0 · Reply

Nuisance Mar. 18 at 5:07 PM

$SBFM Honestly, why should they continue to bring out new news? All the good news that came before was ignored and all of it fizzled out.

1 · Reply

contra7 Mar. 18 at 4:37 PM

$SBFM https://www.aktiencheck.de/news/Artikel-Sunshine_Biopharma_s_March_Milestone_A_Strategic_Financial_Review-19570599

2 · Reply

Kalini67 Mar. 18 at 3:44 PM

$SBFM News coming!

1 · Reply

Market Cap	5.40M
Revenue (ttm)	34.87M
Net Income (ttm)	-5.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-14.71%
Debt to Equity Ratio	0.00

Volume	28,000
Avg Vol	36,324
Day's Range	N/A - N/A
Shares Out	4.91M
Stochastic %K	0%
Beta	1.51
Analysts	Strong Sell
Price Target	$7.00